About the author: Dr. Liz Kwo is currently the staff VP of clinical data analytics at Anthem, and previously cofounded and served as CEO of telemedicine second opinion company InfiniteMD. She received an MD from Harvard Medical, an MBA from Harvard Business School and an MPH from the Harvard T.H. Chan School of Public Health.
COVID-19 has reshaped the way humans interact with technology in...
A new investigation of roughly two million Medicare beneficiary claims suggests that machine learning (ML) could be used to predict which patients are at greatest risk of severe respiratory infections, and to place them in more appropriate care facilities in their area.
The study was published online in the American Journal of Managed Care and funded by the HEALTH[at]SCALE Corporation, a...
Sight Diagnostics, an Israeli startup developing a machine-vision-based finger-prick analysis device, announced today $71 million in Series D funding. Koch Disruptive Technologies, Longliv Ventures and OurCrowd all participated in the round.
According to the company, this newest raise brings its lifetime funding to more than $124 million.
WHAT IT DOES
Founded in 2011, Sight Diagnostics offers an...
A South Korean artificial intelligence (AI) medical software solution is making its way to Saudi Arabia, it has been confirmed.
Dr. Answer – a government-supported tool designed to “offer doctors accurate medical diagnosis by identifying abnormalities in body fluids and tissues” – will undergo clinical trials in the Kingdom. According to a Korean government spokesperson, it is the first time Dr....
When it comes to regions around the world where health tech is in full bloom, it would be hard not to mention Israel. Today we are seeing a rise of health IT innovation and digital health companies rising from this relatively small country in the Middle East.
That is also true when it comes to the country’s largest healthcare organization, Clalit Health Services, which is combining its swaths of...
insitro and Exscientia, two platforms using artificial intelligence to drive the discovery of new drugs, announced this morning the raise of $143 million and $60 million, respectively, from investors.
insitro's oversubscribed Series B round was headed by Andreessen Horowitz, and joined by new backers Canada Pension Plan Investment Board, T. Rowe Price Associates, BlackRock, Casdin Capital, HOF...
Artificial intelligence is knocking on the healthcare industry's doors. From computation-driven R&D for new drugs, to objective image analysis, to mass-scale disease screening and diagnosis, more and more instances of the technology are pitching solutions to some of the industry's most pressing challenges.
Regulators once stood as the primary hurdle for AI and associated technologies like...
Implementation of either an automated or semi-automated deep learning system for diabetic retinopathy screening could lead to cost savings at the health-system level, according to an economic analysis modeling study recently published in The Lancet Digital Health.
Backed by Singapore's Ministry of Health, the investigation looked at data from a national diabetic retinopathy screening program...
About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug and combination product companies on a wide range of FDA regulatory, reimbursement and clinical trial issues. The opinions in this piece are Thompson's and don't necessarily reflect the opinions of MobiHealthNews or HIMSS.
Many appreciate that telemedicine...
Polish telemedicine innovations company StethoMe has announced they will be rolling out their AI wireless stethoscope following recent collaborations with major telemedicine providers MaQuestionMedicale and HomeDoctor. The company is also in talks with other providers across Europe in the hope of expanding operations.
WHAT IT’S FOR
The EU-certified medical device, which records respiratory...
